Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma-Reference-Cited by-同舟云学术

Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma

Published:2023-09 Issue: Volume:30 Page:167-180
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Wang Stacie S.,Pandey Kirti,Watson Katherine A.,Abbott Rebecca C.,Mifsud Nicole A.,Gracey Fiona M.,Ramarathinam Sri H.,Cross Ryan S.,Purcell Anthony W.,Jenkins Misty R.^ORCID

Funder

NHMRC

Cancer Australia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference31 articles.

1. DIPG in Children - What Can We Learn from the Past?;Vanan;Front. Oncol.,2015

2. Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge;Sturm;Nat. Rev. Cancer,2014

3. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas;Khuong-Quang;Acta Neuropathol.,2012

4. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma;Wu;Nat. Genet.,2014

5. Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine Glioma;Buczkowicz;Front. Oncol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-based therapeutic targets in pediatric high-grade glioma;2024-08-28

2. RNA Isoforms as Broad Targets for Cancer Immunotherapy;DNA and Cell Biology;2024-08-01

3. Current immunotherapeutic approaches to diffuse intrinsic pontine glioma;Frontiers in Genetics;2024-05-07

4. TCR-like antibody and GITR signaling lead to effective CAR-T against solid tumor;Molecular Therapy;2024-03